Trial intelligence / Profile preview

ACZONE (Dapsone) Gel in Papulopustular Rosacea

NCT00249782Phase 2Completed

Sponsor
Allergan
Start
Nov 2005
Primary completion
May 2006
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of dapsone in papulopustular rosacea, sponsored by Allergan. Started Nov 2005; status: completed.

02

Drugs

dapsone
03

Conditions

papulopustular rosacea

Beyond the preview

Go deeper on NCT00249782.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00249782.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call